D014481Geographic AreasZ01.107.567.87519640460.522332United StatesFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonDivision of ResearchKaiser Permanente Northern CaliforniaAlanGoAlan S. Go, MD37.80931810000000-122.26769880000000148Go, Alan0000-0001-9109-0811Associate Director, Cardiovascular and Metabolic ConditionsKaiser Permanente WashingtonKatharineBradleyKatharine Bradley, MD, MPH47.61695570000000-122.32966690000000199Bradley, Katharine0000-0003-1933-4425Senior Investigator1Senior Investigator / Research Scientist III5.400270.0129998196research area of0.2496680.005405794084subject area forJacekSkarbinskiJacek Skarbinski, MD225Skarbinski, JacekResearch Scientist III5ProfessorHealth Systems ScienceOffice of the DeanWashington Health Research InstituteMarkSchusterMark Schuster, MD, PhD248Schuster, MarkFounding DeanPaulChungPaul J. Chung, MD, MS250Chung, PaulChair, Health Systems ScienceKaiser Permanente Bernard J. Tyson School of Medicine38319331Feldstein LR, Britton A, Grant L, Wiegand R, Ruffin J, Babu TM, Briggs Hagen M, Burgess JL, Caban-Martinez AJ, Chu HY, Ellingson KD, Englund JA, Hegmann KT, Jeddy Z, Lauring AS, Lutrick K, Martin ET, Mathenge C, Meece J, Midgley CM, Monto AS, Newes-Adeyi G, Odame-Bamfo L, Olsho LEW, Phillips AL, Rai RP, Saydah S, Smith N, Steinhardt L, Tyner H, Vandermeer M, Vaughan M, Yoon SK, Gaglani M, Naleway ALJAMAEffectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years. JAMA. 2024 02 06; 331(5):408-416.JAMA2024-02-06T00:00:002024Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing SARS-CoV-2 Infection in Children and Adolescents Aged 5 to 17 Years.38109092Puls HT, Hall M, Boyd R, Chung PJJAMA pediatricsPublic Benefit Programs and Differential Associations With Child Maltreatment by Race and Ethnicity. JAMA Pediatr. 2024 Feb 01; 178(2):185-192.JAMA Pediatr2024-02-01T00:00:002024Public Benefit Programs and Differential Associations With Child Maltreatment by Race and Ethnicity.38206855Wodi AP, Murthy N, McNally VV, Daley MF, Cineas SMMWR. Morbidity and mortality weekly reportAdvisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024. MMWR Morb Mortal Wkly Rep. 2024 Jan 11; 73(1):6-10.MMWR Morb Mortal Wkly Rep2024-01-11T00:00:002024Advisory Committee on Immunization Practices Recommended Immunization Schedule for Children and Adolescents Aged 18 Years or Younger - United States, 2024.38215160Althoff KN, Stewart C, Humes E, Gerace L, Boyd C, Gebo K, Justice AC, Hyle EP, Coburn SB, Lang R, Silverberg MJ, Horberg MA, Lima VD, Gill MJ, Karris M, Rebeiro PF, Thorne J, Rich AJ, Crane H, Kitahata M, Rubtsova A, Wong C, Leng S, Marconi VC, D'Souza G, Kim HN, Napravnik S, McGinnis K, Kirk GD, Sterling TR, Moore RD, Kasaie PPLoS medicineThe forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study. PLoS Med. 2024 Jan; 21(1):e1004325.PLoS Med2024-01-12T00:00:002024The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.37966844Yu X, Rahman MM, Carter SA, Lin JC, Chow T, Lurmann FW, Chen JC, Martinez MP, Schwartz J, Eckel SP, Chen Z, McConnell R, Xiang AH, Hackman DAJAMA psychiatryNeighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance. JAMA Psychiatry. 2024 Feb 01; 81(2):209-213.JAMA Psychiatry2024-02-01T00:00:002024Neighborhood Disadvantage and Autism Spectrum Disorder in a Population With Health Insurance.true1Associate Director, Cardiovascular and Metabolic ConditionsAssociate Director, Cardiovascular and Metabolic Conditionstrue1Research Scientist IIIResearch Scientist IIItrue1Chair, Health Systems ScienceChair, Health Systems Sciencetrue1Founding DeanFounding Deantrue1Senior InvestigatorSenior Investigator